FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: ADVISORY COMMITTEE; PERIPHERAL AND CENTRAL NERVOUS SYSTEM DRUGS ADVISORY COMMITTEE; TERMINATION AND REESTABLISHMENT

WASHINGTON, July 23 -- Food and Drug Administration has issued a notice called: Advisory Committee; Peripheral and Central Nervous System Drugs Advisory Committee; Termination and Reestablishment.

The notice was published in the Federal Register on July 23 by Grace R. Graham, Deputy Commissioner for Policy, Legislation, and International Affairs.

Summary: The Food and Drug Administration (FDA) is announcing the termination and reestablishment of the Peripheral and Central Nervous System Drugs Advisory Committee by the Commissioner of Food and Drugs (the Commissioner). The Peripheral and Central Nervous System Drugs Advisory Committee was terminated on June 4, 2026, because its charter was not renewed on or before that expiration date. The...